Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana M Franceschi

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
AJR. American Journal of Roentgenology|November 2, 2022
Amyloid-Related Imaging Abnormalities: An UpdateMichelle Roytman, Faizullah Mashriqi, Khaled Al-Tawil, et al.
AJNR. American Journal of Neuroradiology|September 18, 2025
Hybrid [<sup>18</sup>F] Fluoroestradiol Brain PET/CT/MRI for Detection of Estrogen Receptor-Positive Intracranial Metastases Compared with MRI and Vertex-to-Below the Knees PET ImagingFaizullah Mashriqi, Michelle Chen, Graham Keir, et al.
World Journal of Nuclear Medicine|December 4, 2018
Comparison of hybrid 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of peripheral nerve sheath tumors in patients with neurofibromatosis type 1Roy A Raad, Shailee Lala, Jeffrey C Allen, et al.
Clinical Imaging|August 4, 2022
Retrospective review COVID-19 vaccine induced thrombotic thrombocytopenia and cerebral venous thrombosis-what can we learn from the immune responseAna M Franceschi, David R Petrover, Timothy M McMahon, et al.
AJNR. American Journal of Neuroradiology|September 18, 2025
Added Value of Amyloid PET Quantification with the Centiloid Scale in Clinical PracticeAkarsh Vijayashankar, Graham Keir, Matthew Sagnelli, et al.
The Journal of Prevention of Alzheimer'S Disease|June 19, 2025
Monitoring of amyloid related imaging abnormalities: SWI vs T2*-GREDiana M Sima, Thanh Vân Phan, Ana M Franceschi, et al.
Neuro-Degenerative Diseases|November 12, 2025
Clinical practice recommendations of the Swiss Society for Neuroradiology*: Neuroimaging standards for enrollment and disease monitoring in Anti-Amyloid ImmunotherapiesRoland Wiest, Piotr Radojewski, Johanna Maria Lieb, et al.
Stroke|August 31, 2013
Admission insular infarction >25% is the strongest predictor of large mismatch loss in proximal middle cerebral artery strokeShervin Kamalian, Andre Kemmling, Roderick C Borgie, et al.
Radiology|May 13, 2017
Diagnosis of Normal-Pressure Hydrocephalus: Use of Traditional Measures in the Era of Volumetric MR ImagingNityanand Miskin, Hersh Patel, Ana M Franceschi, et al.
World Journal of Nuclear Medicine|July 24, 2018
Visual detection of regional brain hypometabolism in cognitively impaired patients is independent of positron emission tomography-magnetic resonance attenuation correction methodAna M Franceschi, Valentino Abballe, Roy A Raad, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
AJR. American Journal of Roentgenology|November 2, 2022
Amyloid-Related Imaging Abnormalities: An UpdateMichelle Roytman, Faizullah Mashriqi, Khaled Al-Tawil, et al.
AJNR. American Journal of Neuroradiology|September 18, 2025
Hybrid [<sup>18</sup>F] Fluoroestradiol Brain PET/CT/MRI for Detection of Estrogen Receptor-Positive Intracranial Metastases Compared with MRI and Vertex-to-Below the Knees PET ImagingFaizullah Mashriqi, Michelle Chen, Graham Keir, et al.
World Journal of Nuclear Medicine|December 4, 2018
Comparison of hybrid 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of peripheral nerve sheath tumors in patients with neurofibromatosis type 1Roy A Raad, Shailee Lala, Jeffrey C Allen, et al.
Clinical Imaging|August 4, 2022
Retrospective review COVID-19 vaccine induced thrombotic thrombocytopenia and cerebral venous thrombosis-what can we learn from the immune responseAna M Franceschi, David R Petrover, Timothy M McMahon, et al.
AJNR. American Journal of Neuroradiology|September 18, 2025
Added Value of Amyloid PET Quantification with the Centiloid Scale in Clinical PracticeAkarsh Vijayashankar, Graham Keir, Matthew Sagnelli, et al.
The Journal of Prevention of Alzheimer'S Disease|June 19, 2025
Monitoring of amyloid related imaging abnormalities: SWI vs T2*-GREDiana M Sima, Thanh Vân Phan, Ana M Franceschi, et al.
Neuro-Degenerative Diseases|November 12, 2025
Clinical practice recommendations of the Swiss Society for Neuroradiology*: Neuroimaging standards for enrollment and disease monitoring in Anti-Amyloid ImmunotherapiesRoland Wiest, Piotr Radojewski, Johanna Maria Lieb, et al.
Stroke|August 31, 2013
Admission insular infarction >25% is the strongest predictor of large mismatch loss in proximal middle cerebral artery strokeShervin Kamalian, Andre Kemmling, Roderick C Borgie, et al.
Radiology|May 13, 2017
Diagnosis of Normal-Pressure Hydrocephalus: Use of Traditional Measures in the Era of Volumetric MR ImagingNityanand Miskin, Hersh Patel, Ana M Franceschi, et al.
World Journal of Nuclear Medicine|July 24, 2018
Visual detection of regional brain hypometabolism in cognitively impaired patients is independent of positron emission tomography-magnetic resonance attenuation correction methodAna M Franceschi, Valentino Abballe, Roy A Raad, et al.
Pageof 6